Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

International Travel and the Spread of Extended-spectrum Beta-lactamase-producing Escherichia Coli

This study has been completed.
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Johann DD Pitout, University of Calgary
ClinicalTrials.gov Identifier:
NCT01296165
First received: February 14, 2011
Last updated: December 1, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2014
  Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)